Cancer News and Research

Latest Cancer News and Research

Women & Infants Hospital to receive Health Care Innovation award

Health and Human Services Secretary Kathleen Sebelius today announced that Women & Infants Hospital of Rhode Island is among the first batch of organizations selected for Health Care Innovation awards. Made possible by the health care law - the Affordable Care Act - the awards will support 26 innovative projects nationwide that will save money, deliver high quality medical care, and enhance the health care workforce. The preliminary awardees announced today expect to reduce health spending by $254 million over the next three years.

9 May 2012

Study to analyze effectiveness of weight-loss program on participants with Type 2 diabetes

Diabetes affects nearly 24 million people in the United States, most with Type 2 diabetes, a disease which is often coupled with obesity. Concerned by the increasing number of overweight Americans, nutrition experts with the UC San Diego School of Medicine are launching Take Charge, a research study analyzing the effectiveness of a commercial weight-loss program on participants with Type 2 diabetes who have a BMI of 25 - 45.

9 May 2012

Basser Research Center to focus on treatment and prevention of inherited cancers

A $25 million gift to the University of Pennsylvania from alumni Mindy and Jon Gray will establish a center focused on the treatment and prevention of cancers associated with hereditary BRCA mutations.

9 May 2012

iBio receives U.S. patent for iBioModulator platform

iBio, Inc. today announced issuance of a US patent covering compositions of matter and methods of use of modified lichenase B polypeptides comprising the Company's iBioModulator platform.

9 May 2012

Molecule that starts DNA repairs also halts them

Repairing DNA breaks can save a cell's life - but shutting off the repair machinery can be just as critical. How cells accomplish this feat was unknown. However, new research by Johns Hopkins scientists, published in the Feb. 22 issue of Nature, suggests that shutting down the repair machinery relies heavily on the same molecule used to start repair in the first place.

8 May 2012

Ads for “affordable care act” claim to protect Medicare: Really?

Proponents of the Patient Protection and Affordable Care Act have a very costly, tax-payer funded national advertising campaign--- posing as “protectors” of Medicare—even as the massively unpopular law cut $500-$800 billion from Medicare to fund expansion of Medicaid, shifting more medical care services to younger voters.

8 May 2012

Call for cookery lessons in schools to reduce childhood obesity

Health professionals, charity leaders and celebrities, including Steven Gerrard and Jamie Oliver, are calling for cookery lessons to be introduced to schools for all children aged between 4 and 14 years old.

8 May 2012

More teenagers and young adults diagnosed with skin cancer

With summer just around the corner, pediatricians at Johns Hopkins Children's Center are sounding the alarm on a disturbing trend: A growing number of teenagers and young adults diagnosed with skin cancer.

8 May 2012

'Good' cholesterol may not protect against coronary heart disease

A new study by Harvard School of Public Health (HSPH) researchers has found that a subclass of high-density lipoprotein (HDL) cholesterol, the so-called "good" cholesterol, may not protect against coronary heart disease (CHD) and in fact may be harmful.

8 May 2012

Research grants on facioscapulohumeral dystrophy prove useful as genetic basis is found

Businessman Bill Moss’s determination to fight his untreatable muscle-wasting disease may have paid off. Four years ago, Mr Moss, a former Macquarie Bank Executive Director, established a charitable research foundation, FSHD Global, which partly funded the Italian researchers who made the breakthrough.

8 May 2012

Bayer Yakuhin, Santen enter co-promotion agreement for EYLEA Injection in Japan

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer's Japanese subsidiary, Bayer Yakuhin, Ltd., and Santen Pharmaceutical Co., Ltd. entered into a co-promotion agreement for EYLEA aflibercept) Injection in Japan.

From Santen Pharmaceutical Co., Ltd. 8 May 2012

Rexahn submits Phase II protocol for Archexin clinical study for ovarian cancer

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase II protocol for the clinical study of Archexin as a treatment of ovarian cancer to the U.S. Food and Drug Administration (FDA).

8 May 2012

Advaxis commences enrollment in ADXS-HPV Phase 1/2 study for head and neck cancer

Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that two patients have been enrolled into REALISTIC, a Phase 1/2 study being sponsored by Cancer Research UK (CRUK) to investigate the use of ADXS-HPV for the treatment of HPV positive head and neck cancer. HPV is associated with 40-70% of head and neck cancers.

8 May 2012

Screening younger men at risk of prostate cancer can reduce metastatic cancer and deaths

Screening younger men and men at risk of prostate cancer can be beneficial in reducing metastatic cancer and deaths and should not be abandoned, states an article published in CMAJ (Canadian Medical Association Journal).

8 May 2012

BCBSMA institutes enhanced safety measures on coverage for powerful pain killers

In an effort to limit possible prescription narcotic misuse and dependence among its members, Blue Cross Blue Shield of Massachusetts (BCBSMA) announced today that it is instituting enhanced safety measures on how it will cover the use of powerful pain killers.

8 May 2012

Brief empathy training program improves resident physicians interactions with patients

Resident physicians' participation in a brief training program designed to increase empathy with their patients produced significant improvement in how patients perceived their interactions with the residents.

8 May 2012

Certain males at higher risk of infection after receiving experimental HIV vaccine

A long-term follow-up analysis of participants in the Step Study, an international HIV-vaccine trial, has confirmed that certain subgroups of male study participants were at higher risk of becoming infected after receiving the experimental vaccine compared to those who received a placebo.

8 May 2012

First Edition: May 8, 2012

Today's headlines include highlights of how congressional action surrounding the budget and the student loan program could impact health policy.

8 May 2012

Breast brachytherapy with strut-based applicator effective for women with DCIS

Breast brachytherapy with a strut-based applicator appears to be an effective treatment for women who have ductal carcinoma in situ (DCIS) of the breast, according to a groundbreaking study presented at the annual meeting of the American Society of Breast Surgeons, held in Phoenix May 2-4.

8 May 2012

MD Anderson dermatologists applaud upcoming FDA changes to sunscreen labels

Sunscreen labels can be confusing and at times misleading. That's why dermatologists at The University of Texas MD Anderson Cancer Center applaud the upcoming U.S. Food and Drug Administration (FDA) label changes that help consumers understand exactly what they're buying.

8 May 2012

Cancer News and Research

Latest Cancer News and Research

Women & Infants Hospital to receive Health Care Innovation award

Study to analyze effectiveness of weight-loss program on participants with Type 2 diabetes

Basser Research Center to focus on treatment and prevention of inherited cancers

iBio receives U.S. patent for iBioModulator platform

Molecule that starts DNA repairs also halts them

Ads for “affordable care act” claim to protect Medicare: Really?

Call for cookery lessons in schools to reduce childhood obesity

More teenagers and young adults diagnosed with skin cancer

'Good' cholesterol may not protect against coronary heart disease

Research grants on facioscapulohumeral dystrophy prove useful as genetic basis is found

Bayer Yakuhin, Santen enter co-promotion agreement for EYLEA Injection in Japan

Rexahn submits Phase II protocol for Archexin clinical study for ovarian cancer

Advaxis commences enrollment in ADXS-HPV Phase 1/2 study for head and neck cancer

Screening younger men at risk of prostate cancer can reduce metastatic cancer and deaths

BCBSMA institutes enhanced safety measures on coverage for powerful pain killers

Brief empathy training program improves resident physicians interactions with patients

Certain males at higher risk of infection after receiving experimental HIV vaccine

First Edition: May 8, 2012

Breast brachytherapy with strut-based applicator effective for women with DCIS

MD Anderson dermatologists applaud upcoming FDA changes to sunscreen labels

Cancer Research - Second Edition eBook

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Newsletters you may be interested in